Key result
Sotalol administration decreased the mean index of ventricular fibrillation intervals from 19.8 at baseline to 15.8 (P=0.011) in dogs with experimental myocardial infarction.
Why the study?
Does sotalol reduce the dispersion of ventricular refractoriness in an experimental dog model of myocardial infarction?
Does sotalol reduce the dispersion of ventricular refractoriness in an experimental dog model of myocardial infarction?
Absolute Event Rate: 15.8% vs 19.8%
p-value: p=0.011
Sotalol reduces the dispersion of ventricular refractoriness in an experimental model of myocardial infarction, providing a potential mechanism for its antiarrhythmic effects.
Supports sotalol antiarrhythmic mechanism in experimental MI; leaves open translation to human arrhythmia prevention.
UNLABELLED: Dispersion of refractoriness may contribute to the propensity for reentrant arrhythmias. This study was performed to assess the effect of sotalol on the dispersion of refractoriness in experimental myocardial infarction. In 9 mongrel dogs, 14 days after induction of myocardial infarction by an occlusion reperfusion technique, programmed ventricular stimulation and epicardial mapping were performed before and during (3 mg/kg + 0.5 mg/kg per hour) sotalol administration. To assess the spatial distribution of refractoriness, ventricular fibrillation (VF) intervals were analyzed. The rationale for this method is that, during VF, when multiple reentrant wavelets are present, cells are excited as soon as they recover from previous activation. The coefficient of variation (standard deviation x 100) served as an index of spatial distribution of refractoriness. RESULTS: VF was induced before sotalol in 7 dogs and in 5 of 7 during sotalol administration. The mean value of the index VF intervals decreased from 19.8 +/- 2.3 at baseline to 15.8 +/- 2.6 during sotalol (P = 0.011), indicating a more homogeneous distribution of refractoriness. Thus, the antiarrhythmic effects of sotalol may be mediated by its action on the dispersion of refractoriness.
No takes yet. Share an insight, caveat, or question.
Lubiński et al. (1994) studied Experimental myocardial infarction (n=9). Sotalol vs. Baseline (before sotalol administration) was evaluated on Index of spatial distribution of refractoriness (coefficient of variation of VF intervals) (p=0.011). Sotalol administration decreased the mean index of ventricular fibrillation intervals from 19.8 at baseline to 15.8 (P=0.011) in dogs with experimental myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: